Study: ChemoID platform-predicted treatments lead to longer survival for glioblastoma patients

New multi-institutional phase 3 clinical trial data published May 2 in Cell Reports Medicine found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor.

Leave A Comment

Your email address will not be published. Required fields are marked *